Dorset
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
University Hospitals Dorset NHS Foundation Trust
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Atezolizumab
found
8 matches
Open monograph to display formulary status
BNF Category
Atezolizumab
(Tecentriq
®
)
Malignant disease and immunosuppression - Monoclonal antibodies - 08.01.05
Links
Link to Drug Section
Link to document
NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (only in adults with high levels of PD-L1) (08.01.05)
NICE TA520: Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy (08.01.05)
NICE TA525: Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy (08.01.05)
NICE TA584:Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer (08.01.05)
NICE TA638: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer (08.01.05)
NICE TA639:Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer (08.01.05)
NICE TA666: Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma (08.01.05)